AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Profit Motive Behind Anti-Obesity Drugs
This chapter explores the ethical and regulatory issues surrounding the promotion of anti-obesity drugs like Ozempic, drawing troubling parallels to past dangerous medications. The discussion highlights corporate motivations and the lack of long-term safety considerations in the rush to market these pharmaceuticals.